Patient Guide: A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 3 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05282953
Status: 🟢 Enrolling Now
Condition: Retinitis Pigmentosa, Choroideremia, Non-Syndromic Rod-Dominant Inherited Retinal Diseases
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 3 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Sydney, New South Wales
  • Adelaide, South Australia
  • North Adelaide, South Australia

Loading interactive enrollment tools...

The full interactive experience will load momentarily